MedTrace Logo

Trial Comparing Radioactive Seed Localization to Standard Procedure for Non-palpable Breast Cancers

NCT00225927 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 333

Last updated 2011-03-02

No results posted yet for this study

Summary

The purpose of this study is to determine whether a new surgical technique (radioguided seed localization) for localizing nonpalpable breast tumours is better than the standard technique (needle localization).

Conditions

  • Breast Cancer Invasive Nos
  • Stage 0 Breast Carcinoma

Interventions

PROCEDURE

radioguided seed localization for nonpalpable breast cancers

radio-labelled (I-125) titanium seed inserted via needle into nonpalpable breast lesion and gamma probe used to guide surgery

Sponsors & Collaborators

Principal Investigators

  • Peter J Lovrics, MD · McMaster University

  • Mary Townsend · Administrator for Research Programs, McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-06-30
Primary Completion
2010-03-31
Completion
2010-06-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00225927 on ClinicalTrials.gov